Shiwen Zhou

Prof. Shiwen Zhou


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JZJiyin Zhou
Jiyin Zhou
SZShiwen Zhou
Shiwen Zhou
JTJianlin Tang
Jianlin Tang
KZKebin Zhang
Kebin Zhang
LGLixia Guang
Lixia Guang
DLDandan Li
Dandan Li

16 December 2011 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
JZJiyin Zhou
Jiyin Zhou
SZShiwen Zhou
Shiwen Zhou
SZShengya Zeng
Shengya Zeng

31 March 2014 in Current Vascular Pharmacology
Verified
Journal Article
Closed access
PDF file
JZJi-Yin Zhou
Ji-Yin Zhou
LCLawrence Chan
Lawrence Chan
SZShiwen Zhou
Shiwen Zhou
Omentin is an adipokine preferentially produced by visceral adipose tissue with insulin-sensitizing effects. Its expression is reduced in obesity, insulin resistance and type 2 diabetes. Omentin is also positively related with adiponectin, high-density lipoprotein levels and negatively related with body mass index, waist circumference, insulin resistance, triglyceride and leptin levels. Lower plasma omentin levels contribute to the pathogenesis of insulin resistance, type 2 diabetes and cardiovascular diseases in obese or overweight patients. Omentin has anti-inflammatory, antiatherogenic, anti-cardiovascular disease and antidiabetic properties. With respect to vascular biology, omentin causes vasodilatation of blood vessels and attenuates C-reactive protein-induced angiogenesis. The ability of omentin to reduce insulin resistance in conjunction with its anti-inflammatory and anti-atherogenic properties makes it a promising therapeutic target. Thus, omentin may have beneficial effects on the metabolic syndrome and could potentially be used as a biologic marker and/or pharmacologic agent/target in this respect.

19 January 2016 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
JZJiyin Zhou
Jiyin Zhou
SZShiwen Zhou
Shiwen Zhou
CHChunji Huang
Chunji Huang
RXRufu Xu
Rufu Xu
ZZZuo Zhang
Zuo Zhang
GQGui-Sheng Qian
Gui-Sheng Qian
This review provides a critical overview of problem-based learning (PBL) practices in Chinese pharmacy education. PBL has yet to be widely applied in pharmaceutical education in China. The results of those studies that have been conducted are published in Chinese and thus may not be easily accessible to international researchers. Therefore, this meta-analysis was carried out to review the effectiveness of PBL. Databases were searched for studies in accordance with the inclusion criteria. Two reviewers independently performed the study identification and data extraction. A meta-analysis was conducted using Revman 5.3 software. Sixteen randomized controlled trials were included. The meta-analysis revealed that PBL had a positive association with higher theoretical scores (SMD = 1.17, 95 % CI [0.77, 11.57], P < 0.00001). The questionnaire results show that PBL methods are superior to conventional teaching methods in improving students’ learning interest, independent analysis skills, scope of knowledge, self-study, team spirit, and oral expression. This meta-analysis indicates that PBL pedagogy is superior to traditional lecture-based teaching in Chinese pharmacy education. PBL methods could be an optional, supplementary method of pharmaceutical teaching in China. However, Chinese pharmacy colleges and universities should revise PBL curricula according to their own needs, which would maximize the effectiveness of PBL.

1 January 2012 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JZJi-Yin Zhou
Ji-Yin Zhou
SZShiwen Zhou
Shiwen Zhou
The mechanisms leading to diabetic peripheral neuropathy are complex and there is no effective drug to treat it. As an active component of several traditional Chinese medicines, trigonelline has beneficial effects on diabetes with hyperlipidemia. The protective effects and the mechanism of trigonelline on diabetic peripheral neuropathy were evaluated in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Rats were divided into four groups at the end of week 2: control, diabetes, diabetes + trigonelline (40 mg/kg), and diabetes + sitagliptin (4 mg/kg). After 48-week treatment, technologies of nerve conduction, cold and hot immersion test, transmission electron microscopy, real-time PCR, and Western blotting were applied. Serum glucose, serum insulin, insulin sensitivity index, lipid parameters, body weight, sciatic nerve conduction velocity, nociception, glucagon-like peptide-1 receptor mRNA and protein, total and phosphorylated p38 mitogen-activated protein kinases protein expression, malonaldehyde content, and superoxide dismutase activity were altered in diabetic rats, and were near control levels treated with trigonelline. Slight micropathological changes existed in sciatic nerve of trigonelline-treated diabetic rats. These findings suggest that trigonelline has beneficial effects for diabetic peripheral neuropathy through glucagon-like peptide-1 receptor/p38 mitogen-activated protein kinases signaling pathway, nerve conduction velocity, antioxidant enzyme activity, improving micropathological changes of sciatic nerve and decreasing lipid peroxidation.

27 April 2010 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
JZJi-Yin Zhou
Ji-Yin Zhou
ZMZhixian Mo
Zhixian Mo
SZShiwen Zhou
Shiwen Zhou